- Home
- CDTX vs JPC Comparison
CDTX vs JPC Comparison
Compare CDTX & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- JPC
- Stock Information
- Founded
- CDTX 2012
- JPC 2003
- Country
- CDTX United States
- JPC United States
- Employees
- CDTX N/A
- JPC N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- JPC Investment Managers
- Sector
- CDTX Health Care
- JPC Finance
- Exchange
- CDTX Nasdaq
- JPC Nasdaq
- Market Cap
- CDTX 2.8B
- JPC 2.9B
- IPO Year
- CDTX 2015
- JPC N/A
- Fundamental
- Price
- CDTX $109.03
- JPC $8.12
- Analyst Decision
- CDTX Strong Buy
- JPC
- Analyst Count
- CDTX 13
- JPC 0
- Target Price
- CDTX $118.50
- JPC N/A
- AVG Volume (30 Days)
- CDTX 986.8K
- JPC 998.5K
- Earning Date
- CDTX 11-06-2025
- JPC 01-01-0001
- Dividend Yield
- CDTX N/A
- JPC 7.57%
- EPS Growth
- CDTX N/A
- JPC N/A
- EPS
- CDTX N/A
- JPC N/A
- Revenue
- CDTX N/A
- JPC N/A
- Revenue This Year
- CDTX N/A
- JPC N/A
- Revenue Next Year
- CDTX N/A
- JPC N/A
- P/E Ratio
- CDTX N/A
- JPC N/A
- Revenue Growth
- CDTX N/A
- JPC N/A
- 52 Week Low
- CDTX $12.54
- JPC $5.94
- 52 Week High
- CDTX $121.21
- JPC $7.36
- Technical
- Relative Strength Index (RSI)
- CDTX 57.26
- JPC 42.44
- Support Level
- CDTX $93.60
- JPC $8.06
- Resistance Level
- CDTX $107.00
- JPC $8.18
- Average True Range (ATR)
- CDTX 5.83
- JPC 0.06
- MACD
- CDTX -1.38
- JPC -0.01
- Stochastic Oscillator
- CDTX 39.96
- JPC 18.52
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About JPC Nuveen Preferred & Income Opportunities Fund
Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.